CTRI/2019/04/018379尚未招募1 期
A Single-Center Phase I/II Study On Infusion Of Regulatory T Cells For Prevention Of Early Alloreactivity In Haploidentical Hematopoietic Stem Cell Transplantation For Patients With Non-Malignant Disorders
Manashi Chakrabarti Foundation0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)First Transplantation
- •2)Diagnosis of Hemoglobinopathy
- •3)No major organ dysfunction
排除标准
- •1)Patients with uncontrolled bacterial, viral or fungal infections (undergoing appropriate treatment and with progression of clinical symptoms) within 1 month prior to conditioning. Patients with febrile illness or suspected minor infection should await clinical resolution prior to starting conditioning.
- •2)Patients seropositive for the human immunodeficiency virus (HIV)
- •3)Patient with active Hepatitis B or C determined by serology and/or NAAT not on treatment
- •4)Active hepatitis, bridging fibrosis or cirrhosis on liver biopsy (biopsy required for patients on chronic transfusion therapy for > 1 year and evidence of iron overload with ferritin >1000 ng/mL)
研究者
相似试验
进行中（未招募）
不适用
Phase II clinical study for the therapy of cystic fibrosis patients with aspecific mutatioCystic fibrosis patients with F508del-CFTR in homozygous or compound heterozygous with Class I or II mutationsEUCTR2013-001258-82-ITEuropean Institute for Cystic Fibrosis Research (IERFC)
已完成
不适用
A phase 1 clinical pharmacological study with repeated oral doses of KAG-308lcerative ColitisJPRN-UMIN000014009Kaken Pharmaceutical Co., LTD30
已完成
1 期
Phase I/II study on the safety and efficacy of repeated administration of FIT039 transdermal patch for verrucas caused by human papilloma-virusPhase I/II study on the safety and therapeutic efficacy of repeated administration of FIT039 transdermal patch on verrucas caused by human papillomavirusJPRN-UMIN000029695Department of Dermatology, Kyoto University Hospital44
尚未招募
1 期
Mesenchymal Stem Cell Therapy For Covid 19CTRI/2020/08/027043eurogen Brain and Spine Institute
进行中（未招募）
不适用
A study to compare two pediatric formulations to the adult formulation of cobicistat 150 mg tablet in healthy adult volunteersHuman Immunodeficiency Virus (HIV-1) InfectionsMedDRA version: 17.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862EUCTR2015-000466-57-Outside-EU/EEAGilead Sciences, Inc.60